Goldman Sachs analyst Nathan Rich maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and raises the price target from $500 to $650.
Goldman Sachs Maintains Buy on IDEXX Laboratories, Raises Price Target to $650
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.